Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor

Cancer Immunology Immunotherapy

Volumn 45, Issue 5, 1997, Pages 273-279

  Iwasaki, Akiko ^a   Barber, Brian H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer vaccines; Cytotoxic T lymphocytes; DNA immunization; Tumor immunity

Indexed keywords

CANCER VACCINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROTECTION; CELL STIMULATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA CONTENT; IMMUNE RESPONSE; IMMUNIZATION; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; NUCLEOPROTEINS; PLASMIDS; RATS; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA; VIRAL CORE PROTEINS;

EID: 0031449837     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050443     Document Type: Article

References (49)

1. Abrams SI, Hand PH, Tsang KY, Schlom J (1996) Mutant ras epitopes as targets for cancer vaccines. Semin Oncol 23:118
2. Ballinari D, Grazioli L, Sensi ML, Borrello MG, Parmiani G (1985) DBA/2-like minor histocompatibility antigens on a BALB/ c lymphoma. A BALB/c anti-DBA/2 serum which lysis the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors. Int J Cancer 36:617
3. Boon T, Cerottini J, Van den Eynde B, Bruggen P van der, Van Pel A (1994) Tumour antigens recognized by T lymphocytes. Annu Rev Immunol 12:337
4. Chen PW, Wang M, Bronte V, Zhai Y, Rosenberg SA, Restifo NP (1996) Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol 156:224
5. Ciernik FI, Berzofsky JA, Carbone DP (1996) Induction of cytotoxic T lymphocytes and antitumour immunity with DNA vaccine expressing single T cell epitopes. J Immunol 156:2369
6. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H (1984) Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 312:548
7. Conry RM, Lo BA, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT (1994) Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54:1164
8. Conry RM, Lo Buglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT (1995) A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther 2:59
9. Conry RM, Lo Buglio AF, Curiel DT (1996) Polynucleotide-mediated immunization therapy of cancer. Semin Oncol 23:135
10. Corr M, Lee DJ, Carson DA, Tighe H (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184:1555
11. Coulie P, Lehmann F, Lethé B, Herman J, Lurquin C, Andrawiss M, Boon T (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92:7976
12. Doe B, Selby M, Barnett S, Baenziger, Walker CM (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93:8578
13. Eisenstein BI (1989) The polymerase chain reaction: a new method of using molecular genetics for medical diagnosis. N Engl J Med 322:178
14. Fishman P, Azizi E, Shoenfeld Y, Sredni B, Yecheskel G, Ferrone S, Zigelman R, Chaitchik S, Floro S, Djaldetti M (1993) Vitiligo autoantibodies are effective against melanoma. Cancer 72:2365
15. Grabbe S, Beissert D, Shwarz T, Granstein RD (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 16:117
16. Graham RA, Burchell JM, Beverly P, Taylor-Papadimitriou J (1996) Intramuscular immunization with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells. Int J Cancer 65:664
17. Hakim I, Levy S, Levy R (1996) A nine-amino acid peptide from IL-1β augments antitumor immune responses induced by protein and DNA vaccines. J Immunol 157:5503
18. Harris J, Bines S, Das Gupta T (1994) Therapy of disseminated malignant melanoma with recombinant alpha 2b-interferon and piroxicam: clinical results with a report of an unusual response-associated feature (vitiligo) and unusual toxicity (diffuse pulmonary interstitial fibrosis). Med Pediatr Oncol 22:103
19. Houbiers JGA, Nijman HW, Burg SH van der, Drijfhout JW, Kenemans P, Velde CJH van de, Brand A, Momberg F, Kast WM, Melief CJM (1993) In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol 23:2072
20. Houghton AN (1994) Cancer antigens: immune recognition of self and altered self. J Exp Med 180:1
21. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961
22. Irvine KR, Rao JB, Rosenberg SA, Restifo NP (1996) Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastasis. J Immunol 156:238
23. Iwasaki A, Stiernholm NBJ, Chan AK, Berinstein NL, Barber BH (1997) Enhanced cytotoxic T-lymphocyte responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J Immunol 158:4591
24. Iwasaki A, Torres CAT, Ohashi PS, Robinson HL, Barber BH (1997) Both gene gun and intramuscular injection of plasmid DNA induce cytotoxic T-lymphocytes via bone marrow derived antigen presenting cells. J Immunol 159:11
25. Kawakami Y, Robbins PF, Rosenberg SA (1996) Human melanoma antigens recognized by T lymphocytes. Keio J Med 45:100
26. Kim JJ, Ayyavoo V, Bagarazzi M, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 158:816
27. Lenoir GM, Bornkamm GW (1987) Burkitt's lymphoma, a human cancer model for the study of the multistep development fo cancer: proposal for a new scenario.: In: Klein G (ed) Advances in viral oncology, vol 7. Raven, New York, p 173
28. Lethé B, Van den Eynde B, Van Pel A, Corradin G, Boon T (1992) Mouse tumor rejection antigens P815A and P815B : two epitopes carried by a single peptide. Eur J Immunol 22:2283
29. Mandelboim O, Berke G, Fridkin A, Feldman M, Einstein M, Eisenbach L (1994) CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67
30. Melief CJ (1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 58:143
31. Monach PA, Meredith SC, Siegel CT, Schreiber H (1995) A unique tumor antigen produced by a single amino acid substitution. Immunity 2:45
32. Pardoll DM (1993) New strategies for enhancing the immunogenicity of tumors. Curr Opin Immunol 5:719
33. Schlegel R, Phelps WC, Zhang YL, Barbosa M (1988) Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervial carcinoma. EMBO J 7:3181
34. Shirai M, Pendleton DC, Ahlers J, Takeshita T, Newman M, Berzofsky JA (1994) Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol 152:549
35. Skipper J. and Strauss HJ (1993) Identification of two cytotoxic T lymphocyte-recognized epitopes in the ras protein. J Exp Med 177:1493
36. Stevenson F, Zhu D, King CA, Ashworth U, Kumar S, Thompsett A, Hawkins RE (1995) A genetic approach to idiotypic vaccination for B cell lymphoma. Ann NY Acad Sci 772:212
37. Suto R, and Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585
38. Syrengelas AD, Chen TT, and Levy R (1996) DNA immunization induces protective immunity against B-cell lymphoma. Nature Med 2:1038
39. Theobald M, Biggs J, Dittmer D, Levine AJ, Sherman LA (1995) Targeting p53 as a general tumor antigen. Proc Natl Acad Sci USA 92:11993
40. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745
41. Uyttenhove C, Maryanski J, Boon T (1983) Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 157:1040
42. Van den Eynde B, Brichard VG (1995) New tumor antigens recognized by T cells. Curr Opin Immunol 7:674
43. Van den Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173:1373
44. Van Pel A, Vessiere F, Boon T (1983) Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J Exp Med 157:1992
45. Wang B, Merva M, Dang K, Ugen KE, Boyer J, Williams WV, Weiner DB (1994) DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. AIDS Res Hum Retroviruses 10:S35
46. Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP (1995) Active immunotherapy of cancer with non-replicating recombinant fowlpox virus encoding a model tumour-associated antigen. J Immunol 154:4685
47. Ward PL, Koeppen HK, Hurteau T, Rowley DA, Schreiber H (1990) MHC class I and unique antigen expression by tumours that escaped from CD8+ T cell-dependent surveillance. Cancer Res 50:3851
48. Xiang Z, Ertl HC (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129
49. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81:2534